4//SEC Filing
Heberlig Chris 4
Accession 0001104659-19-013177
CIK 0001730430other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:30 PM ET
Size
5.4 KB
Accession
0001104659-19-013177
Insider Transaction Report
Form 4
Heberlig Chris
Exec VP & CFO10% Owner
Transactions
- Award
Share Option
2019-03-04+46,000→ 46,000 totalExercise: $17.92Exp: 2029-03-03→ Class A Common Shares (46,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 4, 2019.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001532217
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:30 PM ET
- Size
- 5.4 KB